Atlas Trials

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

Clinical trial NCT06267144 · UNKNOWN

Trial details

NCT number
NCT06267144
Sponsor
The First Hospital of Jilin University
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer
Start date
2024-01-20
Primary completion
2025-06-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.